tiprankstipranks
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market
Want to see AVBP full AI Analyst Report?

ArriVent BioPharma, Inc. (AVBP) Ownership - Who Owns ArriVent BioPharma, Inc.?

91 Followers

ArriVent BioPharma, Inc. (AVBP) Ownership Overview

9.04%11.43%56.67%11.73%11.13%
56.67% Other Institutional Investors
11.73% ETFs
11.13% Public Companies and
Individual Investors
The ownership structure of ArriVent BioPharma, Inc. (AVBP) stock is a mix of institutional, retail, and individual investors. Approximately 79.83% of the company’s stock is owned by Institutional Investors, 9.04% is owned by Insiders, and 11.13% is owned by Public Companies and Individual Investors.
The ownership structure of ArriVent BioPharma, Inc. (AVBP) stock is a mix of institutional, retail, and individual investors. Approximately 68.10% of the company’s stock is owned by Institutional Investors, 9.04% is owned by Insiders, and 11.73% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 03, 2026
xxxxxxxxxxxxx
$12983320

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,929,117Insider7.97%118,973,663
2,104,353Institution4.27%63,719,809
1,867,386Institution3.79%56,544,448
1,787,003Institution3.62%54,110,451
1,493,078Institution3.03%45,210,402
1,093,877Institution2.22%33,122,596
530,213Insider1.08%16,054,850
495,653Institution1.01%15,008,373
447,770Institution0.91%13,558,476
348,296Institution0.71%10,546,403

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,787,003Institution3.62%54,110,451
1,493,078Institution3.03%45,210,402
495,653Institution1.01%15,008,373
447,770Institution0.91%13,558,476
348,296Institution0.71%10,546,403
328,781Institution0.67%9,955,489
175,463Institution0.36%5,313,020
121,840Institution0.25%3,689,315
91,103Institution0.18%2,758,599
67,367Institution0.14%2,039,873

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,338,764Institution2.72%39,921,942
968,232Institution1.96%29,318,065
934,040Institution1.89%28,908,538
397,748Institution0.81%11,860,845
352,939Institution0.72%10,686,993
247,153Institution0.50%7,483,793
212,622Institution0.43%6,340,388
162,726Institution0.33%5,036,370
138,819Institution0.28%4,307,554
129,814Institution0.26%3,930,768

FAQ

Who Owns ArriVent BioPharma, Inc. (AVBP)?
According to the latest TipRanks data, approximately 56.67% of the company's stock is held by institutional investors, 9.04% is held by insiders, and 11.13% is held by retail investors.
    What percentage of ArriVent BioPharma, Inc. (AVBP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 56.67% of ArriVent BioPharma, Inc. (AVBP) stock is held by institutional investors.
      What percentage of ArriVent BioPharma, Inc. (AVBP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 11.13% of ArriVent BioPharma, Inc. (AVBP) stock is held by retail investors.
        Who owns the most shares of ArriVent BioPharma, Inc. (AVBP)?
        Hillhouse Capital Management, Ltd. owns the most shares of ArriVent BioPharma, Inc. (AVBP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.